Clinical trial
Phase I Study of Ranibizumab Injection for Polypoidal Choroidal Vasculopathy (PEARL)
NCT00424710 is registered in ClinicalTrials.gov with Hawaii Pacific Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase I Study of Ranibizumab Injection for Polypoidal Choroidal Vasculopathy (PEARL)
- Lead sponsor
- Hawaii Pacific Health
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- January 31, 2007
- Completion date
- September 30, 2010
- Enrollment
- 17 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.